These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 11763526

  • 21. [Clinical and vascular effects of ACE inhibitor enalapril in combination with thiaside-like diuretic indapamide in hypertensive outpatients. Results of the multicenter trial POEMA].
    Belenkov IuN, Ageev FT, Orolova IaA, Abrosimova OIu, Volkova EG, Gapon LI, Katel'nitskaia LI, Kondari AO, Patrusheva IF, Fomin IV, Khokhlov RA.
    Ter Arkh; 2007; 79(8):33-8. PubMed ID: 17926468
    [Abstract] [Full Text] [Related]

  • 22. [Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
    Vizir VA, Berezin AE.
    Ter Arkh; 2002; 74(1):52-5. PubMed ID: 11878061
    [Abstract] [Full Text] [Related]

  • 23. Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension.
    Hernández-Guerra M, García-Pagán JC, Turnes J, Bellot P, Deulofeu R, Abraldes JG, Bosch J.
    Hepatology; 2006 Mar; 43(3):485-91. PubMed ID: 16496307
    [Abstract] [Full Text] [Related]

  • 24. Treatment of portal hypertension with nadolol in patients with liver cirrhosis.
    Cervera J, Torres-Zamora M, Gutiérrez-Carreño R, Fierro M, Schaeffer L, Landa L.
    Arch Invest Med (Mex); 1983 Mar; 14(4):331-41. PubMed ID: 6678555
    [No Abstract] [Full Text] [Related]

  • 25. A1166C angiotensin II type 1 receptor gene polymorphism may predict hemodynamic response to losartan in patients with cirrhosis and portal hypertension.
    Sookoian S, Castaño G, García SI, Viudez P, González C, Pirola CJ.
    Am J Gastroenterol; 2005 Mar; 100(3):636-42. PubMed ID: 15743363
    [Abstract] [Full Text] [Related]

  • 26. [Use of enalapril in the preparation of patients with arterial hypertension to the surgical procedures].
    Proshchaev KI.
    Ter Arkh; 2003 Mar; 75(12):43-7. PubMed ID: 14959469
    [Abstract] [Full Text] [Related]

  • 27. [Thiaside diuretics in combination with inhibitors of angiotensin-converting enzyme in patients with diabetes mellitus type 2 comorbid with arterial hypertension].
    Chazova IE, Mychka VB, Duishvili DE.
    Ter Arkh; 2004 Mar; 76(8):28-32. PubMed ID: 15471392
    [Abstract] [Full Text] [Related]

  • 28. [Preliminary experimental study on treatment of portal hypertension with auxiliary partial orthotopic liver transplantation].
    Shi LB, Peng CH, Peng SY, Liu YB, He W, Xu B, Chen XP, Bai MD, Wang Y, Tang Z.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Dec; 16(12):730-3. PubMed ID: 15585146
    [Abstract] [Full Text] [Related]

  • 29. [Efficacy of lisinopril and nebivolol therapy of portal hypertension and kidney dysfunction in patients with liver cirrhosis].
    Fedulenkova LV, Drozdov VN, Mikheeva OM, Petrakov AV.
    Eksp Klin Gastroenterol; 2008 Dec; (5):37-41. PubMed ID: 19145915
    [No Abstract] [Full Text] [Related]

  • 30. Prognostic value of hepatic venous pressure gradient for in-hospital mortality of patients with severe acute alcoholic hepatitis.
    Rincon D, Lo Iacono O, Ripoll C, Gomez-Camarero J, Salcedo M, Catalina MV, Hernando A, Clemente G, Matilla A, Nuñez O, Bañares R.
    Aliment Pharmacol Ther; 2007 Apr 01; 25(7):841-8. PubMed ID: 17373923
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
    Clin Ther; 2004 Sep 01; 26(9):1419-26. PubMed ID: 15531004
    [Abstract] [Full Text] [Related]

  • 33. Clinical usefulness of the angiotensin II receptor antagonist losartan in patients with portal hypertensive gastropathy.
    Wagatsuma Y, Naritaka Y, Shimakawa T, Kanako H, Keiichiro I, Shunichi S, Konno S, Katsube T, Ogawa K.
    Hepatogastroenterology; 2006 Sep 01; 53(68):171-4. PubMed ID: 16608017
    [Abstract] [Full Text] [Related]

  • 34. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M, Takada M, Hirooka K, Isobe F, Yasumura Y.
    J Clin Pharm Ther; 2005 Dec 01; 30(6):603-10. PubMed ID: 16336294
    [Abstract] [Full Text] [Related]

  • 35. [Co-renitek treatment of patients with moderate and severe forms of hypertensive disease].
    Chazova IE, Ratova LG, Dmitriev VV, Khanbalaeva MN, Kotkina TI.
    Ter Arkh; 2003 Dec 01; 75(8):21-6. PubMed ID: 14520845
    [Abstract] [Full Text] [Related]

  • 36. [Effectiveness of enalapril in chronic cor pulmonale].
    Vasilenko GP, Vereshchagina GN, Dolganova DN, Morzhueva NM, Popova SS.
    Klin Med (Mosk); 1999 Dec 01; 77(10):45-7. PubMed ID: 10635655
    [Abstract] [Full Text] [Related]

  • 37. Losartan in preascitic cirrhosis.
    Castaño G, Viudez P, Sookoian S.
    Am J Gastroenterol; 2004 Nov 01; 99(11):2282-3. PubMed ID: 15555016
    [No Abstract] [Full Text] [Related]

  • 38. Haemorheological disturbances in hypertensive type 2 diabetic patients--influence of antihypertensive therapy.
    Kearney-Schwartz A, Virion JM, Stoltz JF, Drouin P, Zannad F.
    Fundam Clin Pharmacol; 2007 Aug 01; 21(4):387-96. PubMed ID: 17635177
    [Abstract] [Full Text] [Related]

  • 39. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar 01; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 40. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
    Laleman W, Van Landeghem L, Van der Elst I, Zeegers M, Fevery J, Nevens F.
    Gastroenterology; 2007 Feb 01; 132(2):709-19. PubMed ID: 17258737
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.